Skip to Content

P-6103

Main Content

American Journal of Hematology | 2025

Five-year real-world safety of Inotuzumab Ozogamicin before hematopoietic stem cell transplantation in B-cell precursor acute lymphoblastic leukemia.

de Lima M, Kebriaei P, Lanza F, Cho C, Popradi G, Kaur M, Zhang MJ, Zhang F, Shah R, Vandendries E, Asomaning K, Dorman S, Stelljes M, Marks DI, Saber W

PubMed
PMID: 39989181

Abstract
Related Articles

CIBMTR Study #: SC17-10